JAKK
JAKKS Pacific, Inc.
JAKK has the edge over LCID overall, supported by lower modeled downside and stronger fundamentals.
LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JAKK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
JAKK's revenue, profitability, cash flow and balance sheet are all currently healthy.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
JAKK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.4x | $7.23 | -80% |
| Fair | 6.4x | $13.62 | -62% |
| Current | 17x | $36.12 | — |
| Expensive | 22x | $47.20 | +31% |
Historical ranges are pointers, not guarantees.
JAKK's PE is in its expensive range at 17x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
JAKK Forward outlook
There aren't enough analyst estimates for JAKK to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
JAKK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.14 | +275% |
| Q2 2026 | $1.40 | -60% |
| Q1 2026 | $0.70 | -83% |
| Q4 2025 | $0.86 | -73% |
| Q3 2025 | $0.57 | -80% |
| Q2 2025 | $3.47 | +27% |
| Q1 2025 | $4.15 | +46% |
| Q4 2024 | $3.14 | -9.8% |
JAKK has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
JAKK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $254.2M | +20% |
| Q2 2026 | $139.2M | +17% |
| Q1 2026 | $106.7M | -5.8% |
| Q4 2025 | $127.1M | -2.8% |
| Q3 2025 | $211.2M | -34% |
| Q2 2025 | $119.1M | -20% |
| Q1 2025 | $113.3M | +26% |
| Q4 2024 | $130.7M | +2.6% |
JAKK's revenue is recovering but still below its 2022 peak: $254M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +0.8 points |
| Q2 2026 | -0.1% | +2.2 points |
| Q1 2026 | -5.2% | -1.9 points |
| Q4 2025 | -6.8% | +4.5 points |
| Q3 2025 | 14% | -7.3 points |
| Q2 2025 | -2.3% | -7.5 points |
| Q1 2025 | -3.3% | +20 points |
| Q4 2024 | -11% | +0.8 points |
JAKK has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over JAKK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
JAKK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.8M | +$361K |
| Q2 2026 | -$161K | +$16.5M |
| Q1 2026 | $16.2M | +$20M |
| Q4 2025 | $31.5M | -37% |
| Q3 2025 | -$12.2M | -225% |
| Q2 2025 | -$16.6M | +$571K |
| Q1 2025 | -$3.8M | +$11.3M |
| Q4 2024 | $50.2M | +$74.7M |
JAKK has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
JAKK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.7% | +428K shares |
| 1 year | +6.5% | +726K shares |
| 3 years | +13% | +1.3M shares |
| 5 years | +91% | +5.7M shares |
| Available history | +301% | +8.9M shares |
JAKK has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
JAKK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.6x | Net Cash |
| Q2 2026 | -3.1x | Net Cash |
| Q1 2026 | -3.7x | Net Cash |
| Q4 2025 | -2.9x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.4x | Net Cash |
JAKK has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
JAKK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 84.2 | Overbought |
| Stochastic | 87.4 | Overbought |
JAKK's weekly RSI is 84 (overbought) and its Stochastic is 87 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
JAKK PE vs Consumer Cyclical Sector
| Metric | JAKK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 6.3% below |
| PE % | 73 | 47 | 26 pts above |
JAKK is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
JAKK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.1 | 20% above |
| 20 week MA | $26.9 | 34% above |
| 50 week MA | $22.9 | 58% above |
| 100 week MA | $22.2 | 63% above |
| 200 week MA | $22.6 | 60% above |
JAKK has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
JAKK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.81 | $5.10 | -48% |
| 2021 | $5.10 | $10.6 | +108% |
| 2022 | $10.6 | $16.5 | +56% |
| 2023 | $16.5 | $35.6 | +115% |
| 2024 | $35.6 | $27.4 | -23% |
| 2025 | $27.4 | $16.8 | -39% |
| 2026 YTD | $16.8 | $36.1 | +115% |
JAKK has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.